Black box warnings are the FDA’s bluntest regulatory instrument short of a recall. Yet despite what headlines, pundits, and ...
The FDA now accepts RWE for device submissions without needing identifiable patient data, facilitating the use of large, de-identified databases. This change addresses previous limitations that ...
FDA loosens data rules for medical devices by allowing real-world evidence without patient identifiers in marketing submissions.
The FDA has recalled thousands of Ziac blood pressure tablets after traces of a cholesterol drug were found during testing, ...
The Trump administration said that had the new prices been in effect last year, Medicare would have saved $12 billion, which would have reduced its spending on those drugs by 44 percent. By Rebecca ...